Flap creation is precise and reliable with 200 kHz laser

Article

Corneal flaps created with a 200 kHz femtosecond laser are safe, reliable and precise in LASIK procedures.

Corneal flaps created with a 200 kHz femtosecond laser are safe, reliable and precise in LASIK procedures, according to a paper in the European Journal of Ophthalmology.

Dr Ramin Khoramnia et al., Department of Ophthalmology, University of Heidelberg, Germany, performed femtosecond laser flap cutting on 36 porcine cadaver eyes using a prototype 200 kHz femtosecond laser.

Eyes were assigned to three thickness groups: 100 µm, 130 µm, or 180 µm cut depth. A micrometer gauge was used to measure the thickness and all flaps underwent histologic evaluation. Flap diameters ranged from 8.0 mm to 9.5 mm and were measured with a sliding calliper.

Mean flap thickness and standard deviation was 96.33±7.45, 134.67±4.96 and 174.59±9.35 for the 100 µm, 130 µm, or 180 µm cut depth, respectively. Mean flap diameter was 8.03±0.15, 8.56±0.10, 9.09±0.10 and 9.54±0.15 for 8.0 mm, 8.5 mm, 9.0 mm and 9.5 mm, respectively.

No complications were recorded and histologic evaluation demonstrated a smooth cut and little to no changes in the structure of the corneal stroma. Morphology and accuracy of the cuts proved to be reliable and precise.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.